3455 — Healthcare & Medical Investment Income Statement
0.000.00%
- ¥42bn
- ¥83bn
- ¥5bn
- 26
- 45
- 38
- 26
Annual income statement for Healthcare & Medical Investment, fiscal year end - July 31st, JPY millions except per share, conversion factor applied.
2021 July 31st | 2022 July 31st | 2023 July 31st | 2024 July 31st | 2025 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,131 | 4,452 | 5,071 | 4,953 | 5,071 |
| Cost of Revenue | |||||
| Gross Profit | 2,357 | 2,555 | 2,961 | 2,787 | 2,811 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,985 | 2,114 | 2,349 | 2,400 | 2,511 |
| Operating Profit | 2,146 | 2,338 | 2,722 | 2,553 | 2,560 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,833 | 2,015 | 2,348 | 2,106 | 2,043 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,831 | 2,013 | 2,346 | 2,104 | 2,042 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,831 | 2,013 | 2,346 | 2,104 | 2,042 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,831 | 2,013 | 2,346 | 2,104 | 2,042 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5,888 | 6,008 | 6,527 | 5,853 | 5,679 |
| Dividends per Share | |||||
| Special Dividends per Share |